Experienced in WT1-Related Wilms Tumor Syndromes

Dr. Steven C. Buck

Hematology Oncology | Oncology
Stillwater Medical Center Authority
1301 W 6th Ave, 
Stillwater, OK 
Accepting New Patients
46 Years of Experience

Experienced in WT1-Related Wilms Tumor Syndromes
Stillwater Medical Center Authority
1301 W 6th Ave, 
Stillwater, OK 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Steven Buck is a Hematologist Oncology specialist and an Oncologist in Stillwater, Oklahoma. Dr. Buck has been practicing medicine for over 46 years and is rated as an Experienced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Hemangioma Thrombocytopenia Syndrome, Breast Cancer, Paget Disease of the Breast, and Thrombocytopenia. Dr. Buck is currently accepting new patients.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Year
1979
Specialties
Hematology Oncology
Oncology
Licenses
Internal Medicine in OK
Hospital Affiliations
Stillwater Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Medica
  • EPO
  • HMO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

STILLWATER MEDICAL CENTER AUTHORITY
1301 W 6th Ave, Stillwater, OK 74074
Call: 580-762-3770
Other Locations
STILLWATER MEDICAL CENTER AUTHORITY
417 Fairview Ave, Ponca City, OK 74601
Call: 580-762-3770

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


2 Clinical Trials

JUNIPER: A Randomized Phase 3 Study of Abemaciclib Plus Best Supportive Care Versus Erlotinib Plus Best Supportive Care in Patients With Stage IV NSCLC With a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy
JUNIPER: A Randomized Phase 3 Study of Abemaciclib Plus Best Supportive Care Versus Erlotinib Plus Best Supportive Care in Patients With Stage IV NSCLC With a Detectable KRAS Mutation Who Have Progressed After Platinum-Based Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: April 22, 2025
Intervention Type: Drug
Study Drugs: Abemaciclib, Erlotinib
Study Phase: Phase 3
Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus Cyclophosphamide, Doxorubicin and Vincristine (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS)
Phase III Randomized Clinical Trial of Lurbinectedin (PM01183)/Doxorubicin Versus Cyclophosphamide, Doxorubicin and Vincristine (CAV) or Topotecan as Treatment in Patients With Small-Cell Lung Cancer (SCLC) Who Failed One Prior Platinum-containing Line (ATLANTIS)
Enrollment Status: Completed
Publish Date: October 28, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

2 Total Publications

Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 30, 2016
View All 2 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Adanma A. Ayanambakkam-Attanathi
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Adanma A. Ayanambakkam-Attanathi
Hematology Oncology | Hematology | Oncology

Ou Health Partners Inc

800 Ne 10th St, Ouhp Stephenson Cancer C, 
Oklahoma City, OK 
 (50.1 miles away)
405-271-4088
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Adanma Ayanambakkam-Attanathi is a Hematologist Oncology specialist and a Hematologist in Oklahoma City, Oklahoma. Dr. Ayanambakkam-Attanathi is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, and Adult Soft Tissue Sarcoma. Dr. Ayanambakkam-Attanathi is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Sanjaykumar J. Hapani
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Sanjaykumar J. Hapani
Hematology Oncology | Hematology | Oncology

Oklahoma Cancer And Blood Specialists LLC

11100 Hefner Pointe Dr, Suite A, 
Oklahoma City, OK 
 (46.6 miles away)
405-752-0871
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sanjaykumar Hapani is a Hematologist Oncology specialist and a Hematologist in Oklahoma City, Oklahoma. Dr. Hapani is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Clear Cell Sarcoma, WT1-Related Wilms Tumor Syndromes, Familial Colorectal Cancer, Adult Soft Tissue Sarcoma, and Bone Marrow Aspiration. Dr. Hapani is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jess F. Armor
Hematology Oncology | Hematology | Oncology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Jess F. Armor
Hematology Oncology | Hematology | Oncology

Mercy Clinic Oklahoma Communities

4300 Mcauley Blvd, 
Oklahoma City, OK 
 (45.9 miles away)
405-936-5455
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Jess Armor is a Hematologist Oncology specialist and a Hematologist in Oklahoma City, Oklahoma. Dr. Armor is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Small Lymphocytic Lymphoma (SLL), Large-Cell Immunoblastic Lymphoma, Multiple Myeloma, Primary Lymphoma of the Brain, and Bone Marrow Aspiration. Dr. Armor is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Buck's expertise for a condition
ConditionClose
    • Distinguished
    • Breast Cancer
      Dr. Buck is
      Distinguished
      . Learn about Breast Cancer.
      See more Breast Cancer experts
    • Hemangioma Thrombocytopenia Syndrome
      Dr. Buck is
      Distinguished
      . Learn about Hemangioma Thrombocytopenia Syndrome.
      See more Hemangioma Thrombocytopenia Syndrome experts
    • Advanced
    • Acute Megakaryoblastic Leukemia
      Dr. Buck is
      Advanced
      . Learn about Acute Megakaryoblastic Leukemia.
      See more Acute Megakaryoblastic Leukemia experts
    • Lung Cancer
      Dr. Buck is
      Advanced
      . Learn about Lung Cancer.
      See more Lung Cancer experts
    • Paget Disease of the Breast
      Dr. Buck is
      Advanced
      . Learn about Paget Disease of the Breast.
      See more Paget Disease of the Breast experts
    • Pleuropulmonary Blastoma
      Dr. Buck is
      Advanced
      . Learn about Pleuropulmonary Blastoma.
      See more Pleuropulmonary Blastoma experts
    • Thrombocytopenia
      Dr. Buck is
      Advanced
      . Learn about Thrombocytopenia.
      See more Thrombocytopenia experts
    • Experienced
    • Acute Myeloblastic Leukemia with Maturation
      Dr. Buck is
      Experienced
      . Learn about Acute Myeloblastic Leukemia with Maturation.
      See more Acute Myeloblastic Leukemia with Maturation experts
    • Acute Myeloblastic Leukemia without Maturation
      Dr. Buck is
      Experienced
      . Learn about Acute Myeloblastic Leukemia without Maturation.
      See more Acute Myeloblastic Leukemia without Maturation experts
    • Acute Myeloid Leukemia (AML)
      Dr. Buck is
      Experienced
      . Learn about Acute Myeloid Leukemia (AML).
      See more Acute Myeloid Leukemia (AML) experts
    • Adult Soft Tissue Sarcoma
      Dr. Buck is
      Experienced
      . Learn about Adult Soft Tissue Sarcoma.
      See more Adult Soft Tissue Sarcoma experts
    • ALK-Positive Non-Small Cell Lung Cancer
      Dr. Buck is
      Experienced
      . Learn about ALK-Positive Non-Small Cell Lung Cancer.
      See more ALK-Positive Non-Small Cell Lung Cancer experts
    • Anaplastic Thyroid Cancer
      Dr. Buck is
      Experienced
      . Learn about Anaplastic Thyroid Cancer.
      See more Anaplastic Thyroid Cancer experts
    View All 77 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2025 All Rights Reserved